Preliminary observations on peripheral inflammatory markers in NIR-PIT and ICI-treated recurrent head and neck squamous cell carcinoma | Synapse
March 3, 2026
Preliminary observations on peripheral inflammatory markers in NIR-PIT and ICI-treated recurrent head and neck squamous cell carcinoma
Key Points
Peripheral inflammatory markers correlated with treatment response in recurrent head and neck squamous cell carcinoma, observing diverse immune reactions.
Key findings indicate that specific markers potentially influence outcomes, with varied responses to both NIR-PIT and ICI treatments.
Analysis focuses on inflammatory processes in head and neck tumors using patient-derived data sets to assess immune changes over time.
The findings highlight the importance of monitoring inflammatory markers for personalized therapies; further studies are needed for broader validation.